Neuropeptides Involved in the Pathophysiology of Schizophrenia and Major Depression

ISSN： 1029-8428

Source： Neurotoxicity Research, Vol.4, Iss.5, 2002-01, pp. : 453-468

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Resting-State Brain Activity in Schizophrenia and Major Depression: A Quantitative Meta-Analysis

By Khn Simone Gallinat Jrgen

Schizophrenia Bulletin, Vol. 39, Iss. 2, 2013-03 ,pp. : 358-365

Oxford University Press

Access to resources Recommend Favorite

Sensitivity and Specificity of Memory Dysfunction in Schizophrenia: A Comparison With Major Depression

By Egeland Jens Sundet Kjetil Rund Bjørn Rishovd Asbjørnsen Arve Hugdahl Kenneth Landrø Nils Inge Lund Anders Roness Atle Stordal Kirsten I.

Journal of Clinical and Experimental Neuropsychology (Neuropsychology, Developm, Vol. 25, Iss. 1, 2003-02 ,pp. : 79-93

Routledge Ltd

Access to resources Recommend Favorite

A test of the tripartite model's prediction of anhedonia's specificity to depression: patients with major depression versus patients with schizophrenia

By Joiner T.E. Brown J.S. Metalsky G.I.

Psychiatry Research, Vol. 119, Iss. 3, 2003-08 ,pp. : 243-250

Elsevier

Access to resources Recommend Favorite

Pathophysiology of early onset schizophrenia

By Kyriakopoulos Marinos Frangou Sophia

International Review of Psychiatry, Vol. 19, Iss. 4, 2007-08 ,pp. : 315-324

Informa Healthcare

Access to resources Recommend Favorite

The role of dopamine for the pathophysiology of schizophrenia

By Meisenzahl E. M. Schmitt G. J. Scheuerecker J. Möller H. -J.

International Review of Psychiatry, Vol. 19, Iss. 4, 2007-08 ,pp. : 337-345

Informa Healthcare

Access to resources Recommend Favorite